Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/56129
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThomas, D.-
dc.contributor.authorVadas, M.-
dc.contributor.authorLopez, A.-
dc.date.issued2004-
dc.identifier.citationExpert Opinion on Biological Therapy, 2004; 4(6):869-879-
dc.identifier.issn1471-2598-
dc.identifier.issn1744-7682-
dc.identifier.urihttp://hdl.handle.net/2440/56129-
dc.description.abstractHaematopoiesis is regulated by a wide variety of glycoprotein hormones, including stem cell factor, granulocyte-macrophage colony-stimulating factor, thrombopoietin and IL-3. These haematopoietic growth factors (HGFs) share a number of properties, including redundancy, pleiotropy, autocrine and paracrine effects, receptor subunit oligomerisation and similar signal transduction mechanisms, yet each one has a unique spectrum of haematopoietic activity. Ongoing studies with knockout mice have discovered previously unrecognised physiological roles for HGFs, linking haematopoiesis to innate immunity, pulmonary physiology and bone metabolism. The regulation of stem cells by HGFs within niches of the bone marrow microenvironment is now well recognised and similar mechanisms appear to exist in the regulation of other stem cell compartments. Alternative signalling strategies, other than tyrosine kinase activation and phosphotyrosine cascades, may account for some of the more subtle differences between HGFs. Accumulating evidence suggests that some, but not all, HGF receptors can transduce a genuine lineage-determining signal at certain points in haematopoiesis. Further studies, primarily at the receptor level, are needed to determine the mechanisms of instructive signalling, which may include phosphoserine cascades. Novel haematopoietic regulators, as well as the development of biological therapies, including growth factor antagonists and peptide mimetics, are also discussed.-
dc.description.statementofresponsibilityDaniel Thomas, Mathew Vadas and Angel Lopez-
dc.language.isoen-
dc.publisherAshley Publications Ltd-
dc.subjectBone Marrow Cells-
dc.subjectStem Cells-
dc.subjectAnimals-
dc.subjectMice, Knockout-
dc.subjectHumans-
dc.subjectMice-
dc.subjectLeukemia-
dc.subjectLung Diseases-
dc.subjectGrowth Substances-
dc.subjectPeptides-
dc.subjectGranulocyte-Macrophage Colony-Stimulating Factor-
dc.subjectInterleukin-3-
dc.subjectMacrophage Colony-Stimulating Factor-
dc.subjectThrombopoietin-
dc.subjectHematopoietic Cell Growth Factors-
dc.subjectStem Cell Factor-
dc.subjectHematopoiesis-
dc.titleRegulation of haematopoiesis by growth factors - emerging insights and therapies-
dc.typeJournal article-
dc.identifier.doi10.1517/14712598.4.6.869-
pubs.publication-statusPublished-
dc.identifier.orcidLopez, A. [0000-0001-7430-0135]-
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.